Downloads

  1. Deepening Digitalization In Drug Discovery At PTC Therapeutics 5/28/2026

    Digital integration of physicochemical property prediction transforms how chemists evaluate compounds, enabling faster analysis, stronger structure, and more informed decisions across libraries.

  2. Accelerating Structure Verification Across Novartis 5/28/2026

    Automated structure verification integrated into open-access NMR workflows cuts review time dramatically while maintaining confidence in results. See how smart parameter optimization improves efficiency.

  3. How GSK Are Revolutionizing HTE 5/28/2026

    High-throughput chemistry delivers speed and efficiency, but only with the right digital backbone. See how integrated automation and analytics help chemists extract more value from every plate.

  4. The Future Of DMTA In Drug Discovery And Development 5/28/2026

    AI‑enabled DMTA cycles connect design, experimentation, and analysis through structured data and automation, reducing manual handoffs while accelerating discovery, development, and CMC decision‑making.

  5. In Vitro Biology 5/28/2026

    Curia’s discovery biology team accelerates your program toward the clinic and commercialization with our best-in-class, customizable solutions.

  6. Integrated Drug Discovery 5/28/2026

    Integrated drug discovery greatly benefits programs by blending various scientific disciplines into a unified team focused on your project.

  7. Medicinal Chemistry 5/28/2026

    Curia was the first CRO to provide contract medicinal chemistry services to the pharmaceutical industry.

  8. Structural Biology Services 5/28/2026

    At Curia, our team of expert protein chemists and structural biologists brings the advanced experience and technology needed to support all your structural biology services needs.

  9. What Makes An RNA Platform Investable? Lessons From The Last Wave Of Biotech Financing 5/28/2026

    RNA investing has shifted from hype to scalability, forcing companies to prove manufacturability, delivery strength, and platform-wide value.

  10. Synaptic Regeneration And The Future Of Alzheimer's R&D 5/22/2026

    For too long, treating Alzheimer’s disease has been a case of “managed decline.” We need to move beyond slowing disease progression toward achieving tangible functional recovery.